A new trading day began on Monday, with 2seventy bio Inc (NASDAQ: TSVT) stock price up 3.88% from the previous day of trading, before settling in for the closing price of $3.61. TSVT’s price has ranged from $1.67 to $6.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 73.45% over the last five years. Meanwhile, its annual earnings per share averaged 83.91%. With a float of $48.24 million, this company’s outstanding shares have now reached $50.63 million.
The firm has a total of 274 workers. Let’s measure their productivity. In terms of profitability, gross margin is 51.77%, operating margin of -313.09%, and the pretax margin is -207.25%.
2seventy bio Inc (TSVT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of 2seventy bio Inc is 6.32%, while institutional ownership is 87.95%. The most recent insider transaction that took place on Nov 18 ’24, was worth 13,182. In this transaction Director of this company sold 3,900 shares at a rate of $3.38, taking the stock ownership to the 23,752 shares. Before that another transaction happened on Nov 18 ’24, when Company’s Director proposed sale 3,900 for $3.38, making the entire transaction worth $13,182.
2seventy bio Inc (TSVT) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.11 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 83.91% per share during the next fiscal year.
2seventy bio Inc (NASDAQ: TSVT) Trading Performance Indicators
Here are 2seventy bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.86, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of 2seventy bio Inc (TSVT)
Analysing the last 5-days average volume posted by the [2seventy bio Inc, TSVT], we can find that recorded value of 0.38 million was lower than the volume posted last year of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 30.61%. Additionally, its Average True Range was 0.30.
During the past 100 days, 2seventy bio Inc’s (TSVT) raw stochastic average was set at 32.02%, which indicates a significant decrease from 34.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.03% in the past 14 days, which was higher than the 68.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.57, while its 200-day Moving Average is $4.62. Now, the first resistance to watch is $3.88. This is followed by the second major resistance level at $4.00. The third major resistance level sits at $4.17. If the price goes on to break the first support level at $3.59, it is likely to go to the next support level at $3.42. Now, if the price goes above the second support level, the third support stands at $3.30.
2seventy bio Inc (NASDAQ: TSVT) Key Stats
With a market capitalization of 221.00 million, the company has a total of 51,588K Shares Outstanding. Currently, annual sales are 100,390 K while annual income is -217,570 K. The company’s previous quarter sales were 13,530 K while its latest quarter income was -9,930 K.
